Crohn’s disease is a poorly understood autoimmune reaction that causes inflammation of the gastrointestinal tract. Here's more info.
PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing ...
PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and ...